PDCD1 and neoplasm: Engagement of PD-1 with its ligand PD-L1, which is frequently upregulated on the surface of cancer cells, including OSCC cells, and stromal elements, suppresses cytotoxic T-cell activity and promotes T-cell exhaustion, enabling tumor immune evasion and escape [216].